Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
Generate:Biomedicines is seeking a Senior Clinical Trial Manager to lead Phase 3 clinical trials within our Clinical Development team. This role involves managing global studies, ensuring operational excellence, and collaborating across various functions. Candidates should possess experience in clinical trial management, particularly in late-stage studies, and have strong communication and organizational skills.
Get AI-powered advice on this job and more exclusive features.
Generate:Biomedicines is a new kind of therapeutics company – existing at the intersection of machine learning, biological engineering, and medicine – pioneering Generative Biology to create breakthrough medicines where novel therapeutics are computationally generated, instead of being discovered. The Company has built a machine learning-powered biomedicines platform with the potential to generate new drugs across a wide range of biologic modalities. This platform represents a potentially fundamental shift in what is possible in the field of biotherapeutic development.
We pursue this audacious vision because we believe in the unique and revolutionary power of generative biology to radically transform the lives of billions, with an outsized opportunity for patients in need. We are seeking collaborative, relentless problem solvers that share our passion for impact to join us!
Generate:Biomedicines was founded in 2018 by Flagship Pioneering and has received nearly $700 million in funding, providing the resources to rapidly scale the organization. The Company has offices in Somerville and Andover, Massachusetts with 300+ employees.
The Role:
Generate Biomedicines is seeking an experienced and collaborative Senior Clinical Trial Manager (Sr. CTM) to lead the execution of Phase 3 clinical trials within our Clinical Development team. This role will report to the Sr. Director of Late Stage Clinical Operations and be responsible for managing global, late-stage studies intended to support regulatory submissions and eventual product approval.
The Sr. CTM will work cross-functionally across Clinical Development, Regulatory Affairs, Clinical Supply, and Data Management, while serving as a key point of contact for CROs, vendors, and clinical sites. This is a critical role for ensuring operational excellence, compliance, and delivery in high-stakes studies where quality and precision are paramount.
Here's how you will contribute:
The Ideal Candidate will have:
Generate:Biomedicines is committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies : Generate:Biomedicines does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Generate:Biomedicines or its employees is strictly prohibited unless contacted directly by the Company’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Generate:Biomedicines and the Company will not owe any referral or other fees with respect thereto.
Referrals increase your chances of interviewing at Generate:Biomedicines by 2x
Medical insurance
Paid paternity leave
Tuition assistance
Disability insurance
Vision insurance
401(k)
Paid maternity leave
Get notified about new Clinical Trial Manager jobs in United States.
United States $150,000.00-$165,000.00 2 weeks ago
Washington, DC $125,000.00-$150,000.00 1 month ago
United States $122,000.00-$152,000.00 1 week ago
United States $129,000.00-$177,000.00 1 day ago
New York City Metropolitan Area $50.00-$60.00 1 day ago
United States $174,000.00-$210,000.00 1 week ago
United States $150,000.00-$220,000.00 2 weeks ago
California, United States $90.00-$110.00 1 week ago
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.